Aptose Biosciences, Inc.

Aptose Biosciences, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Aptose Biosciences, Inc. is not a good value stock. Aptose Biosciences, Inc. is not very popular among insiders. Aptose Biosciences, Inc. is a mediocre stock to choose.
Log in to see more information.
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, resea...
APTO Fundamental Data by TradingView

News

StockNews.com Initiates Coverage on Aptose Biosciences (NASDAQ:APTO)
StockNews.com Initiates Coverage on Aptose Biosciences (NASDAQ:APTO)

Zolmax Research analysts at StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO - Get Free Report) (TSE:APS) in a note issued to investors on Tuesday. The brokerage set a "hold...\n more…

Aptose Biosciences (NASDAQ:APTO) Coverage Initiated by Analysts at StockNews.com
Aptose Biosciences (NASDAQ:APTO) Coverage Initiated by Analysts at StockNews.com

Ticker Report Investment analysts at StockNews.com assumed coverage on shares of Aptose Biosciences (NASDAQ:APTO - Get Free Report) (TSE:APS) in a research report issued on Tuesday. The firm set a "hold" rating on...\n more…

Aptose Announces Results from Special Meeting of Shareholders
Aptose Announces Results from Special Meeting of Shareholders

Globe Newswire SAN DIEGO and TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ( Aptose or the Company ) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing...\n more…

Aptose Biosciences (NASDAQ:APTO) Coverage Initiated by Analysts at StockNews.com
Aptose Biosciences (NASDAQ:APTO) Coverage Initiated by Analysts at StockNews.com

Ticker Report StockNews.com assumed coverage on shares of Aptose Biosciences (NASDAQ:APTO - Free Report) (TSE:APS) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on...\n more…

Aptose Biosciences (NASDAQ:APTO) Receives New Coverage from Analysts at StockNews.com
Aptose Biosciences (NASDAQ:APTO) Receives New Coverage from Analysts at StockNews.com

Zolmax Equities research analysts at StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO - Get Free Report) (TSE:APS) in a report released on Monday. The firm set a "hold" rating on...\n more…

Aptose Biosciences Secures Convertible $10M Loan from Hanmi
Aptose Biosciences Secures Convertible $10M Loan from Hanmi

TipRanks Financial Blog Aptose Biosciences (APS) has shared an announcement. Aptose Biosciences Inc. has secured a $10 million loan from Hanmi Pharmaceutical Co., Ltd., repayable by Januar...\n more…